Monte Rosa Therapeutics, Inc.

Contributing Author

Recent Articles by Monte Rosa Therapeutics, Inc.

Jul-03	Monte Rosa Announces Publication in Science of Key Insights that Enable Next Generation Molecular Glue Degrader Medicines GLUE GlobeNewswire
Jun-10	Monte Rosa Therapeutics Announces FDA Clearance of IND Application for MRT-8102, a NEK7-Directed Molecular Glue Degrader for the Treatment of Multiple Inflammatory Diseases GLUE GlobeNewswire
May-28	Monte Rosa Therapeutics to Participate in the Jefferies Global Healthcare Conference GLUE GlobeNewswire
May-08	Monte Rosa Therapeutics Announces First Quarter 2025 Financial Results and Business Updates GLUE GlobeNewswire